MRNA Vaccines And Therapeutics Industry Research Report 2023
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
Highlights
The global mRNA Vaccines & Therapeutics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics.
The mRNA Vaccines & Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global mRNA Vaccines & Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines & Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Product Type Insights
Global markets are presented by mRNA Vaccines & Therapeutics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the mRNA Vaccines & Therapeutics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
mRNA Vaccines & Therapeutics segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the mRNA Vaccines & Therapeutics market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the mRNA Vaccines & Therapeutics market.
mRNA Vaccines & Therapeutics segment by Application
Infectious Disease
Cancer
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the mRNA Vaccines & Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the mRNA Vaccines & Therapeutics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of mRNA Vaccines & Therapeutics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of mRNA Vaccines & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
Highlights
The global mRNA Vaccines & Therapeutics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics.
The mRNA Vaccines & Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global mRNA Vaccines & Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines & Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Product Type Insights
Global markets are presented by mRNA Vaccines & Therapeutics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the mRNA Vaccines & Therapeutics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
mRNA Vaccines & Therapeutics segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the mRNA Vaccines & Therapeutics market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the mRNA Vaccines & Therapeutics market.
mRNA Vaccines & Therapeutics segment by Application
Infectious Disease
Cancer
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the mRNA Vaccines & Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the mRNA Vaccines & Therapeutics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of mRNA Vaccines & Therapeutics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of mRNA Vaccines & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global mRNA Vaccines & Therapeutics Market Size (2018-2029) & (US$ Million)
2.2.2 Global mRNA Vaccines & Therapeutics Sales (2018-2029)
2.2.3 Global mRNA Vaccines & Therapeutics Market Average Price (2018-2029)
2.3 mRNA Vaccines & Therapeutics by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
2.4 mRNA Vaccines & Therapeutics by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Infectious Disease
2.4.3 Cancer
3 Market Competitive Landscape by Manufacturers
3.1 Global mRNA Vaccines & Therapeutics Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global mRNA Vaccines & Therapeutics Sales (M Doses) of Manufacturers (2018-2023)
3.3 Global mRNA Vaccines & Therapeutics Revenue of Manufacturers (2018-2023)
3.4 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2018-2023)
3.5 Global mRNA Vaccines & Therapeutics Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
3.8 Global Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
3.9 Global mRNA Vaccines & Therapeutics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Moderna Therapeutics
4.1.1 Moderna Therapeutics Company Information
4.1.2 Moderna Therapeutics Business Overview
4.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
4.1.5 Moderna Therapeutics Recent Developments
4.2 CureVac
4.2.1 CureVac Company Information
4.2.2 CureVac Business Overview
4.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
4.2.5 CureVac Recent Developments
4.3 Translate Bio
4.3.1 Translate Bio Company Information
4.3.2 Translate Bio Business Overview
4.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
4.3.5 Translate Bio Recent Developments
4.4 BioNTech
4.4.1 BioNTech Company Information
4.4.2 BioNTech Business Overview
4.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
4.4.5 BioNTech Recent Developments
4.5 Sangamo Therapeutics
4.5.1 Sangamo Therapeutics Company Information
4.5.2 Sangamo Therapeutics Business Overview
4.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.5.5 Sangamo Therapeutics Recent Developments
4.6 Argos Therapeutics
4.6.1 Argos Therapeutics Company Information
4.6.2 Argos Therapeutics Business Overview
4.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
4.6.5 Argos Therapeutics Recent Developments
4.7 In-Cell-Art
4.7.1 In-Cell-Art Company Information
4.7.2 In-Cell-Art Business Overview
4.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
4.7.5 In-Cell-Art Recent Developments
6.8 eTheRNA
4.8.1 eTheRNA Company Information
4.8.2 eTheRNA Business Overview
4.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
4.8.5 eTheRNA Recent Developments
4.9 Ethris
4.9.1 Ethris Company Information
4.9.2 Ethris Business Overview
4.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
4.9.5 Ethris Recent Developments
4.10 Tiba Biotechnology
4.10.1 Tiba Biotechnology Company Information
4.10.2 Tiba Biotechnology Business Overview
4.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
4.10.5 Tiba Biotechnology Recent Developments
5 Global mRNA Vaccines & Therapeutics Market Scenario by Region
5.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global mRNA Vaccines & Therapeutics Sales by Region: 2018-2029
5.2.1 Global mRNA Vaccines & Therapeutics Sales by Region: 2018-2023
5.2.2 Global mRNA Vaccines & Therapeutics Sales by Region: 2024-2029
5.3 Global mRNA Vaccines & Therapeutics Revenue by Region: 2018-2029
5.3.1 Global mRNA Vaccines & Therapeutics Revenue by Region: 2018-2023
5.3.2 Global mRNA Vaccines & Therapeutics Revenue by Region: 2024-2029
5.4 North America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.4.1 North America mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.4.3 North America mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.5.1 Europe mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.5.3 Europe mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.6.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.6.3 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.7.1 Latin America mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.7.3 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.8.1 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.8.3 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global mRNA Vaccines & Therapeutics Sales by Type (2018-2029)
6.1.1 Global mRNA Vaccines & Therapeutics Sales by Type (2018-2029) & (M Doses)
6.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2018-2029)
6.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2018-2029)
6.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2018-2029)
6.3 Global mRNA Vaccines & Therapeutics Price by Type (2018-2029)
7 Segment by Application
7.1 Global mRNA Vaccines & Therapeutics Sales by Application (2018-2029)
7.1.1 Global mRNA Vaccines & Therapeutics Sales by Application (2018-2029) & (M Doses)
7.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2018-2029)
7.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2018-2029)
6.2.1 Global mRNA Vaccines & Therapeutics Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2018-2029)
7.3 Global mRNA Vaccines & Therapeutics Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 mRNA Vaccines & Therapeutics Value Chain Analysis
8.1.1 mRNA Vaccines & Therapeutics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 mRNA Vaccines & Therapeutics Production Mode & Process
8.2 mRNA Vaccines & Therapeutics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 mRNA Vaccines & Therapeutics Distributors
8.2.3 mRNA Vaccines & Therapeutics Customers
9 Global mRNA Vaccines & Therapeutics Analyzing Market Dynamics
9.1 mRNA Vaccines & Therapeutics Industry Trends
9.2 mRNA Vaccines & Therapeutics Industry Drivers
9.3 mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
9.4 mRNA Vaccines & Therapeutics Industry Restraints
10 Report Conclusion
11 Disclaimer
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global mRNA Vaccines & Therapeutics Market Size (2018-2029) & (US$ Million)
2.2.2 Global mRNA Vaccines & Therapeutics Sales (2018-2029)
2.2.3 Global mRNA Vaccines & Therapeutics Market Average Price (2018-2029)
2.3 mRNA Vaccines & Therapeutics by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
2.4 mRNA Vaccines & Therapeutics by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Infectious Disease
2.4.3 Cancer
3 Market Competitive Landscape by Manufacturers
3.1 Global mRNA Vaccines & Therapeutics Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global mRNA Vaccines & Therapeutics Sales (M Doses) of Manufacturers (2018-2023)
3.3 Global mRNA Vaccines & Therapeutics Revenue of Manufacturers (2018-2023)
3.4 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2018-2023)
3.5 Global mRNA Vaccines & Therapeutics Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
3.8 Global Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
3.9 Global mRNA Vaccines & Therapeutics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Moderna Therapeutics
4.1.1 Moderna Therapeutics Company Information
4.1.2 Moderna Therapeutics Business Overview
4.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
4.1.5 Moderna Therapeutics Recent Developments
4.2 CureVac
4.2.1 CureVac Company Information
4.2.2 CureVac Business Overview
4.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
4.2.5 CureVac Recent Developments
4.3 Translate Bio
4.3.1 Translate Bio Company Information
4.3.2 Translate Bio Business Overview
4.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
4.3.5 Translate Bio Recent Developments
4.4 BioNTech
4.4.1 BioNTech Company Information
4.4.2 BioNTech Business Overview
4.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
4.4.5 BioNTech Recent Developments
4.5 Sangamo Therapeutics
4.5.1 Sangamo Therapeutics Company Information
4.5.2 Sangamo Therapeutics Business Overview
4.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.5.5 Sangamo Therapeutics Recent Developments
4.6 Argos Therapeutics
4.6.1 Argos Therapeutics Company Information
4.6.2 Argos Therapeutics Business Overview
4.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
4.6.5 Argos Therapeutics Recent Developments
4.7 In-Cell-Art
4.7.1 In-Cell-Art Company Information
4.7.2 In-Cell-Art Business Overview
4.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
4.7.5 In-Cell-Art Recent Developments
6.8 eTheRNA
4.8.1 eTheRNA Company Information
4.8.2 eTheRNA Business Overview
4.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
4.8.5 eTheRNA Recent Developments
4.9 Ethris
4.9.1 Ethris Company Information
4.9.2 Ethris Business Overview
4.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
4.9.5 Ethris Recent Developments
4.10 Tiba Biotechnology
4.10.1 Tiba Biotechnology Company Information
4.10.2 Tiba Biotechnology Business Overview
4.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
4.10.5 Tiba Biotechnology Recent Developments
5 Global mRNA Vaccines & Therapeutics Market Scenario by Region
5.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global mRNA Vaccines & Therapeutics Sales by Region: 2018-2029
5.2.1 Global mRNA Vaccines & Therapeutics Sales by Region: 2018-2023
5.2.2 Global mRNA Vaccines & Therapeutics Sales by Region: 2024-2029
5.3 Global mRNA Vaccines & Therapeutics Revenue by Region: 2018-2029
5.3.1 Global mRNA Vaccines & Therapeutics Revenue by Region: 2018-2023
5.3.2 Global mRNA Vaccines & Therapeutics Revenue by Region: 2024-2029
5.4 North America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.4.1 North America mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.4.3 North America mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.5.1 Europe mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.5.3 Europe mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.6.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.6.3 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.7.1 Latin America mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.7.3 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa mRNA Vaccines & Therapeutics Market Facts & Figures by Country
5.8.1 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2018-2029)
5.8.3 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global mRNA Vaccines & Therapeutics Sales by Type (2018-2029)
6.1.1 Global mRNA Vaccines & Therapeutics Sales by Type (2018-2029) & (M Doses)
6.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2018-2029)
6.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2018-2029)
6.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2018-2029)
6.3 Global mRNA Vaccines & Therapeutics Price by Type (2018-2029)
7 Segment by Application
7.1 Global mRNA Vaccines & Therapeutics Sales by Application (2018-2029)
7.1.1 Global mRNA Vaccines & Therapeutics Sales by Application (2018-2029) & (M Doses)
7.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2018-2029)
7.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2018-2029)
6.2.1 Global mRNA Vaccines & Therapeutics Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2018-2029)
7.3 Global mRNA Vaccines & Therapeutics Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 mRNA Vaccines & Therapeutics Value Chain Analysis
8.1.1 mRNA Vaccines & Therapeutics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 mRNA Vaccines & Therapeutics Production Mode & Process
8.2 mRNA Vaccines & Therapeutics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 mRNA Vaccines & Therapeutics Distributors
8.2.3 mRNA Vaccines & Therapeutics Customers
9 Global mRNA Vaccines & Therapeutics Analyzing Market Dynamics
9.1 mRNA Vaccines & Therapeutics Industry Trends
9.2 mRNA Vaccines & Therapeutics Industry Drivers
9.3 mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
9.4 mRNA Vaccines & Therapeutics Industry Restraints
10 Report Conclusion
11 Disclaimer